Behavioral, toxic, and neurochemical effects of sydnocarb, a novel psychomotor stimulant: Comparisons with methamphetamine

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 3, 1999, Pages 1298-1310

  Witkin, J M ^a   Savtchenko, N ^b   Mashkovsky, M ^b   Beekman, M ^a,c   Munzar, P ^a   Gasior, M ^a,d,e   Goldberg, S R ^a   Ungard, J T ^a   Kim, J ^a   Shippenberg, T ^a   Chefer, V ^a,f,g  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g PAVLOV INSTITUTE OF PHYSIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DOPAMINE; ECOPIPAM; HALOPERIDOL; METHAMPHETAMINE; SPIPERONE; SYDNOCARB;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DEPRESSION; DRUG DEPENDENCE; DRUG DISCRIMINATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; SCHIZOPHRENIA; STEREOTYPY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BENZAZEPINES; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; DISCRIMINATION LEARNING; DOPAMINE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HALOPERIDOL; MALE; MAZE LEARNING; METHAMPHETAMINE; MICE; MOTOR ACTIVITY; PSYCHOMOTOR PERFORMANCE; SELF ADMINISTRATION; STEREOTYPED BEHAVIOR; SYDNONES;

EID: 0032982424     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Acri JB, Seidleck B and Witkin, JM (1996) Effects of benztropine on behavioral and toxic effects of cocaine: Comparison with atropine and the selective dopamine uptake inhibitor 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-propyl)-piperazine. J Pharmacol Exp Ther 277:198-206.
2. Altshuler RA (1973) Sydnocarb - A novel stimulator of CNS J. Pharmacol Toxicol 1:18.
3. Bergman J, Madras BK, Johnson SE and Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates. III Self-administration by squirrel monkeys. J Pharmacol Exp Ther 251:150-155.
4. Camp DM, Browman KE and Robinson TE (1994) The effects of methamphetamine and cocaine on motor behavior and extracellular dopamine in the ventral striatum of Lewis versus Fischer 344 rats. Brain Res 668:180-93.
5. Chait LD, Uhlenhuth EH and Johanson CE (1987) Reinforcing and subjective effects of several anorectics in normal human volunteers. J Pharmacol Exp Ther 242: 777-783.
6. Chipkin RE, Iorio LC, Coffin VC, McQuade RD, Berger JG and Barnett A (1988) Pharmacological profile of SCH39166: A dopamine D1 selective benzonapthazine with potential antipsychotic activity. J Pharmacol Exp Ther 247:1093-1102.
7. Cooper SJ and Dourish CT (1990) An introduction to the concept of stereotypy and a historical perspective on the role of brain dopamine, in Neurobiology of Stereotyped Behaviour (Cooper SJ and Dourish CT eds) pp 1-24, Oxford University Press, Oxford.
8. Department of Health and Human Services (1997) Year-End Preliminary Estimates from the 1996 Drug Abuse Warning Network, DAWN Series D-3, Rockville, MD.
9. Di Chiara G (1995) The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 38:95-137.
10. R). Pol J Pharmacol Pharm 33:141-147.
11. Gainetdinov RR, Sotnikova TD, Grekhova TV and Rayevsky KS (1997) Effect of a psychostimulant drug Sydnocarb on rat brain dopaminergic transmission in vivo. Eur J Pharmacol 340:53-58.
12. Harvey JM (1987) Behavioral pharmacology of central nervous system stimulants. Neuropharmacology 26:887-892.
13. Holtzman SG (1990) Discriminative stimulus effects of drugs: Relationship to potential for abuse, in Testing and Evaluation of Drugs of Abuse, Modern Methods in Pharmacology, (Adler MW and Cowan A eds) vol 6, pp 193-210, Wiley-Liss, New York.
14. Johnston LD, O'Malley PM and Bachman JG (1997) National Survey Results on Drug Use from the Monitoring the Future Study, 1975-1994. U. S. Department of Health and Human Services, Rockville, MD.
15. Katz JL (1989) Drugs as reinforcers: Pharmacological and behavioural factors, in The Neuropharmacological Basis of Reward (Liebman JM and Cooper SJ eds) pp 164-213, Oxford University Press, Oxford.
16. Katz JL (1990) Models of relative reinforcing efficacy of drugs and their predictive utility. Behav Pharmacol 1:283-302.
17. Litchfield JT and Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 95:99-113.
18. Mashkovsky MD, Altshuler RA, Avrutsky GYa, Aleksandrovich YuA and Smulevich RA (1971) Experimental and clinical study on new psychostimulator Sydnocarb. S Korsakov's J Neuropath/Psychiatr 71, issue 11:1704-1709 (in Russian).
19. 1 values. J Pharmacol Exp Ther 251:238-246.
20. Menon MK, Clark WG and Fleming RM (1973) Blockade of the central effects of d-amphetamine sulfate by amantadine hydrochloride. Eur J Pharmacol 21:311-317.
21. Munzar P, Baumann MH, Shoaib M and Goldberg SR (1999) Effects of dopamine and serotonin-releasing agents on methamphetamine discrimination and self-administration in rats. Psychopharmacology 141:287-296.
22. Peachey JE, Rogers B, Brien JF, Maclean A and Rodgers D (1976) Measurement of acute and chronic effects of methamphetamine in the mouse. Psychopharmacologia 48:271-275.
23. Pickens R, Meisch RA and McGuire LF (1967) Methamphetamine reinforcement in rats. Psychon Sci Sect Anim Physiol Psychol 8:371-373.
24. 1 and D2 receptors in the locomotor stimulation produced by (+)-amphetamine in naive and dopamine-depleted mice. Pharmacol Toxicol 64:72-77.
25. Rothman RB and Glowa JR (1995) A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Mol Neurobiol 11:1-19.
26. Rudenko GM and Altshuler RA (1978) Experimental and clinical study of Sydnocarb. Hung Pharmacotherapy, 124:150-154 (in Russian).
27. Schuster CR and Johanson CE (1988) Relationship between the discriminative stimulus properties and subjective effects of drugs, in Psychopharmacology, Series 4: Transduction Mechanisms of Drug Stimuli (Colpaert FC and Balster RL eds) pp 161-175, Springer-Verlag, Berlin.
28. Slotnick BM and Leonard CM (1975) A Stereotaxic Atlas of the Albino Mouse Fore-brain. U. S. Department of Health, Education and Welfare, Rockville, MD.
29. Sulzer D, Chen T-K, Lau YY, Kristensen H, Rayport S and Ewing A (1995) Amphetamine redistributes dopamine from synaptic vesicles to cytosol and promotes reverse transport. J Neurosci 15:4102-4108.
30. Tirelli E and Witkin JM (1995) Differential effects of direct and indirect dopamine agonists on the induction of gnawing in C57BL/6J mice. J Pharmacol Exp Ther 237:7-15.
31. Valueva LA and Tozhanova NM (1982) Correction by Sydnocarb of side effects produced by tranquilizers of benzodiazepine series. J Neurol Neurosurg Psychiatry 9:92-97.
32. Voronina TA and Tozhanova NM (1981) Effects of stimulants on tranquilizing, hypnotic and myorelaxant effects of phenazepam. Pharmacol Toxicol 2:155-158.
33. Westernik BHC, Hofsteede RM, Tuntler J and de Vries JB (1989) Use of calcium antagonism for the characterization of drug-evoked dopamine release from brain of conscious rats determined by microdialysis. J Neurochem 52:722-729.
34. Witkin JM (1994) Pharmacotherapy of cocaine abuse: Preclinical development. Neurosci Biobehav Rev 18:121-142.
35. Witkin JM and Katz JL (1992) Preclinical assessment of cocaine toxicity: Mechanisms and pharmacotherapy. Acute Cocaine Intoxication: Current Methods of Treatment (National Institute on Drug Abuse Research Monograph) 123:44-69.
36. Witkin JM, Nichols DE, Terry P and Katz JL (1991) Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J Pharmacol Exp Ther 257:706-713.
37. Witkin JM, Ricaurte GA and Katz JL (1990) Behavioral effects of N-methylamphetamine and N,N-dimethylamphetamine in rats and squirrel monkeys. J Pharmacol Exp Ther 253:466-474.
38. Zetterström T, Sharp T, Marsden CA and Ungerstedt U (1983) In vivo measurement of extracellular dopamine and its metabolites by intracerebral dialysis: Changes after d-amphetamine. J Neurochem 41:1769-1733.